USPTO Patent Practice

Mary Till, Finnegan

Mary C. Till is of counsel in Finnegan, Henderson, Farabow, Garrett & Dunner LLP’s Washington, DC office. She leverages her over 30 years of experience in patent law to provide patent prosecution counseling services to a broad range of clients. Drawing on her insider’s perspective with the U.S. Patent and Trademark Office (USPTO), her capabilities range from the representation of large corporations to startups and universities needing patent procurement, portfolio evaluations, and portfolio management services. Mary’s technical background encompasses diverse technologies across various industries within the pharmaceutical and biotech technology sectors, including small molecules, antibodies, pro-drugs, drug formulations, and vaccines. Mary possesses a rare understanding of the intersection of patent law with the Food and Drug Administration’s (FDA) regulatory laws, having been involved in the USPTO’s collaboration group with the FDA for several years while also being principally responsible for administration of the patent term restoration provisions of the Hatch-Waxman Act on behalf of the USPTO. Prior to joining Finnegan, Mary was a senior legal advisor in the Office of Patent Legal Administration at the USPTO for nearly 19 years. She holds a J.D. from American University, Washington College of Law.